Avon Anew Clinical, Cellu-Sculpt Drive Q3 Skin Care Sales Growth
This article was originally published in The Rose Sheet
Executive Summary
Avon's U.S. skin care business advanced 22% in the third quarter, boosted in part by the strong debut of Anew Clinical, President and Chief Operating Officer Susan Kropf said during an Oct. 28 analyst call